Circle of Innovation Quality of life after radiotherapy and cancer + The complexity of tumours poses a challenge to effective treatment. For example, there is not only one type of lung cancer, but there are many different types. + Maastricht UMC+ conducts fundamental research into the molecular characteristics of tumours. + In addition, we use imaging to characterise tumours in a unique way; we call this radiomics. + Using big data, imaging is combined with patient databases and molecular data to specify tumours. Maastricht UMC+ Circle of Innovation® LIMITING ADVERSE EFFECTS OF TREATMENT + Maastricht UMC+ distinguishes itself for its focus on the prevention of adverse effects and therefore the promotion of maintaining functional capacity. + ZON-PTC will be one of the three proton therapy centres in the Netherlands. + Proton therapy allows a much more accurate radiation of tumours while sparing the surrounding healthy tissue. HOW DO WE MAP THE CHARACTERISTICS OF TUMOURS? MAINTAINING FUNCTIONAL CAPACITY FOR A BETTER QUALITY OF LIFE INNOVATIVE THERAPIES AND PREDICTION MODELS + Maastricht UMC+ conducts clinical trials to reduce the number or severity of treatments. This prevents adverse effects and also cuts the costs. + Maintaining functional capacity results in a better quality of life and earlier return to employment. + Maastricht UMC+ created several spin-offs in the field of oncology: Cimaas, Radiomics BV, etc. + Knowledge and innovations are shared via the OncoZON network. + Cancer is the leading cause of death in the Netherlands. + Maastricht UMC+ makes prediction models to select a treatment for each individual patient that will give the highest tumour control and fewest adverse effects possible. + We are able to predict, for instance, which patients will benefit from a sophisticated treatment such as proton therapy (within ZON-PTC). + Maastricht UMC+ tests innovative combinations of chemotherapy, immunotherapy and radiotherapy. Healthy living Creating value Generating knowledge Innovating healtcare
Circles_of_innovations_ENG
To see the actual publication please follow the link above